Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pharmadrug Inc (LMLLF)
Pharmadrug Inc (LMLLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade LMLLF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0041 +53.66%
on 05/25/23
0.0094 -32.98%
on 05/08/23
-0.0013 (-17.11%)
since 05/02/23
3-Month
0.0041 +53.66%
on 05/25/23
0.0150 -58.00%
on 03/20/23
-0.0084 (-57.14%)
since 03/02/23
52-Week
0.0041 +53.66%
on 05/25/23
0.0358 -82.40%
on 06/06/22
-0.0257 (-80.31%)
since 06/02/22

Most Recent Stories

More News
PharmaDrug Brings On Advisor to Maximize Shareholder Value With Its Underlying Assets

Toronto, Ontario--(Newsfile Corp. - May 23, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is announcing that it has appointed David Posner to its Advisory Committee...

LMLLF : 0.0063 (-8.70%)
PHRX.CN : 0.005 (-50.00%)
PharmaDrug Announces Cease Trade Order

Toronto, Ontario--(Newsfile Corp. - May 8, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), is announcing that the Ontario Securities Commission has issued a "failure...

LMLLF : 0.0063 (-8.70%)
PHRX.CN : 0.005 (-50.00%)
PharmaDrug Announces Non-Brokered Offering of $100,000 of Convertible Secured Debentures

Toronto, Ontario--(Newsfile Corp. - April 14, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0063 (-8.70%)
PHRX.CN : 0.005 (-50.00%)
PharmaDrug Collaborates with PharmaTher for Development of DMT Transdermal Patch

PharmaDrug is positioning to become a leader of DMT-based therapeutics for ocular disease and neuropsychiatric conditionsToronto, Ontario--(Newsfile Corp. - February 22, 2023) - PharmaDrug Inc. (CSE: PHRX)...

LMLLF : 0.0063 (-8.70%)
PHRX.CN : 0.005 (-50.00%)
PharmaDrug Announces Plans for First-In-Human Clinical Study with PD-001 (Enteric-Coated Cepharanthine -2HCL) in Esophageal Cancer

Toronto, Ontario--(Newsfile Corp. - February 13, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0063 (-8.70%)
PHRX.CN : 0.005 (-50.00%)
PharmaDrug Advances Programs in Oncology with Filing of PCT Application Detailing the Use of PD-001 for Treatment of Prostate Cancer

Toronto, Ontario--(Newsfile Corp. - January 31, 2023) - PharmaDrug Inc. (CSE: PHRX) (OTCQB: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development...

LMLLF : 0.0063 (-8.70%)
PHRX.CN : 0.005 (-50.00%)
Khiron Completes Acquisition of Pharmadrug Production GmbH, Establishing German Pharmaceutical Distribution Capabilities

Acquisition provides Khiron with an EU-GMP European manufacturing and distribution hub for medical cannabis and other pharmaceutical products The acquisition...

LMLLF : 0.0063 (-8.70%)
KHRNF : 0.0310 (-7.46%)
PHRX.CN : 0.005 (-50.00%)
Khiron to Acquire EU-GMP-Certified German Pharmaceuticals Manufacturer and Wholesaler, Expanding its European Footprint

The acquisition will accelerate Khiron's growth in Europe by controlling the complete value chain for its products and gaining direct access to German...

KHRNF : 0.0310 (-7.46%)
PHRX.CN : 0.005 (-50.00%)
LMLLF : 0.0063 (-8.70%)
KHRN.VN : 0.040 (unch)
Proactive news headlines including VR Resources, Dalrada Corp, Cloud DX and Kenorland Minerals

New York , July 14, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies

TRRXF : 0.0400 (unch)
COR : 169.41 (-0.22%)
CAMZF : 0.0676 (-11.05%)
FTCO : 6.9200 (-1.14%)
PAI : 11.70 (+0.52%)
INOTF : 0.0010 (unch)
BRAG : 3.30 (-0.60%)
BRGGF : 10.3800 (-4.50%)
VRRCF : 0.1690 (+1.08%)
AUSA.CN : 0.025 (unch)
AUSAF : 0.0190 (unch)
KLD : 102.74 (+0.82%)
Proactive news headlines including Royal Road Minerals, Great Panther Mining, PharmaDrug, Codebase Ventures and Nextech AR Solutions

New York , June 22, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

MYCOF : 0.2340 (+11.43%)
VLNS : 0.7602 (+0.03%)
VLNCF : 1.4090 (-7.90%)
BUZZ.CN : 0.060 (unch)
LMLLF : 0.0063 (-8.70%)
VMC : 202.73 (+1.98%)
BUSXF : 7.5000 (-6.25%)
RRDMF : 0.0957 (-17.00%)
EDXC : 0.0371 (+13.46%)
PSYBF : 0.0200 (-14.16%)
BIOC : 2.13 (+3.90%)
AUSA.CN : 0.025 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.0073
2nd Resistance Point 0.0071
1st Resistance Point 0.0067
Last Price 0.0063
1st Support Level 0.0061
2nd Support Level 0.0059
3rd Support Level 0.0055

See More

52-Week High 0.0358
Fibonacci 61.8% 0.0237
Fibonacci 50% 0.0199
Fibonacci 38.2% 0.0162
Last Price 0.0063
52-Week Low 0.0041

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar